Unknown PHASE2 INTERVENTIONAL 1-arm NCT02803840

Low-dose Radiotherapy for Diffuse Large B-cell Lymphoma

A Phase II Trial of Low-Dose Radiotherapy for the Palliation of Patients With Diffuse Large B-cell Lymphoma

Sponsor: Centro di Riferimento Oncologico - Aviano

Conditions Lymphoma

Updated 6 times since 2017 Last updated: Jun 16, 2016 Started: Jul 31, 2011 Primary completion: Jun 30, 2016 Completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Lymphoma, this trial is ongoing. The trial is conducted by Centro di Riferimento Oncologico - Aviano and has accumulated 6 data snapshots since 2011. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jul 2018 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Jun 2018 — Jul 2018 [monthly]

Recruiting PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

Jul 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centro di Riferimento Oncologico - Aviano

Data source: Centro di Riferimento Oncologico - Aviano

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aviano, Italy